JAMES INVESTMENT RESEARCH INC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JAMES INVESTMENT RESEARCH INC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$369,112
-7.7%
4,2920.0%0.05%
-3.9%
Q2 2023$400,014
+98183.5%
4,2920.0%0.05%
-5.6%
Q1 2023$407
-5.1%
4,292
+0.5%
0.05%
-10.0%
Q4 2022$429
-99.9%
4,2700.0%0.06%
+15.4%
Q3 2022$364,000
-0.8%
4,2700.0%0.05%
+6.1%
Q2 2022$367,000
-4.4%
4,2700.0%0.05%
+22.5%
Q1 2022$384,0004,2700.04%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders